FeatureBase (formerly Molecula)
Builds data virtualization software to secure access to large datasets.
| USD | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 200 % | 67 % | 80 % | 67 % | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Molecula, through its flagship product FeatureBase, operates in the data analytics and artificial intelligence (AI) market. The company provides a feature-oriented database platform designed to power real-time analytics and machine learning applications. FeatureBase is engineered to deliver ultra-low latency, enabling organizations to access and query data in milliseconds, which is crucial for optimizing internet traffic, detecting anomalies, and improving customer experiences. Molecula serves a diverse range of industries including financial services, healthcare, life sciences, public sector, and technology. The business model revolves around offering its database platform as a service, generating revenue through subscription fees and licensing. By closing the gap between data and decision-making, Molecula helps organizations unlock the power of real-time analytics and AI, thereby optimizing business processes and enhancing operational efficiency.
Keywords: real-time analytics, machine learning, ultra-low latency, feature-oriented database, data access, anomaly detection, customer experience, financial services, healthcare, technology.